Improving Glycemic Control With Electrical Stimulation
Improving Glycemic Control With Electrical Stimulation in Mexican-Americans
Who can join
Ages 18 and older · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * Overweight/Obese (BMI ≥25) * Sedentary Lifestyle: Physical Activity Level\<1.4 * Less than 150min/week of structured Exercise Exclusion Criteria: * Use of anti-hypertensive, lipid-lowering or insulin sensitizing medications * Excessive alcohol, drug abuse, smoking * Pregnant Women * Unwilling to adhere to the study Intervention
About the study
Once written consent is obtained, the participant will be provided with an accelerometer to be worn for 7 days to assess current physical activity levels. Subjects will be provided with a standardized diet (55/15/30% CHO/PRO/FAT) prior to collection of pre-intervention data of insulin sensitivity. Individuals will then participate in an 8-week electrical stimulation intervention (30min/day, 3x/week) and randomized into placebo/control, NMES, resistance training combined with NMES (RT +NMES), or resistance training (RT) group (n=15 per group), followed by collection of post-intervention data. The control group will receive electrical stimulation up to sensory level, the NMES group will receive stimulation up to tolerable intensity to induce visible muscle contraction, the RT+ NMES will receive stimulation up to tolerable intensity during resistance training, and the RT group will only receive exercise training. Pre-and post-intervention data includes measurements for body composition, resting metabolic rate, VO2max, insulin sensitivity, and comprehensive blood work.
What is being tested
- Neuromuscular Electrical Stimulation (Sensory) (device)
- Neuromuscular Electrical Stimulation (device)
- Resistance Training (other)
Sponsor: University of Texas, El Paso · Participants: 60 · Started: Aug 9, 2022
Contact the study team
- Sudip Bajpeyi, PhD · Phone: 9157475461
Official record on ClinicalTrials.gov — NCT03947697
Locations in the U.S.
| Texas | University of Texas at El Paso, El Paso |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.